Increased expression of TLR7 in CD8+ T cells leads to TLR7-mediated activation and accessory cell-dependent IFN-γ production in HIV type 1 infection

AIDS Research and Human Retroviruses

Volumn 25, Issue 12, 2009, Pages 1287-1295

  Song, Yang ^a   Zhuang, Yan ^a   Zhai, Song ^a   Huang, Dedong ^a   Zhang, Ying ^a   Kang, Wenzhen ^a   Li, Xinhong ^a   Liu, Qingquan ^a   Yu, Qigui ^b   Sun, Yongtao ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8;

ACCESSORY CELL; ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERFERON PRODUCTION; MALE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LECTINS, C-TYPE; LIGANDS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; TOLL-LIKE RECEPTOR 7; VIRAL LOAD;

EID: 73149111309     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0303     Document Type: Article

References (46)

1. Koup RA, Safrit JT, Cao Y, et al.: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68(7):4650-4655.
2. Walker BD, Chakrabarti S, Moss B, et al.: HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature 1987;328(6128):345-348.
3. Hoffenbach A, Langlade-Demoyen P, Dadaglio G, et al.: Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 1989;142(2):452-462. (Pubitemid 19039962)
4. Clerici M, Lucey DR, Zajac RA, et al.: Detection of cytotoxic T lymphocytes specific for synthetic peptides of gp160 in HIV-seropositive individuals. J Immunol 1991;146(7):2214-2219.
5. Carmichael A, Jin X, Sissons P, and Borysiewicz L: Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: Differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177(2):249-256.
6. Ogg GS, Kostense S, Klein MR, et al.: Longitudinal phenotypic analysis of human immunodeficiency virus type 1- specific cytotoxic T lymphocytes: Correlation with disease progression. J Virol 1999;73(11):9153-9160.
7. Callan MF, Tan L, Annels N, et al.: Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo. J Exp Med 1998; 187(9):1395-1402.
8. Reusser P, Cathomas G, Attenhofer R, Tamm M, and Thiel G: Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis 1999; 180(2):247-253.
9. Akira S, Takeda K, and Kaisho T: Toll-like receptors: Critical proteins linking innate and acquired immunity. Nat Immunol 2001;2(8):675-680. (Pubitemid 32747155)
10. Krieg AM: CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002;20:709-760.
11. Barton GM: Viral recognition by Toll-like receptors. Semin Immunol 2007;19(1):33-40.
12. Schlaepfer E and Speck RF: Anti-HIV activity mediated by natural killer and CD8+ cells after Toll-like receptor 7/8 triggering. PLoS One 2008;3(4):e1999.
13. Beignon AS, McKenna K, Skoberne M, et al.: Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005;115(11): 3265-3275.
14. Kaisho T and Akira S: Pleiotropic function of Toll-like receptors. Microbes Infect 2004;6(15):1388-1394.
15. Romagnani C, Della Chiesa M, Kohler S, et al.: Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4+ T helper cells and CD4+ CD25hi T regulatory cells. Eur J Immunol 2005;35(8):2452-2458.
16. Kaisho T and Akira S: Regulation of dendritic cell function through Toll-like receptors. Curr Mol Med 2003;3(8):759-771. (Pubitemid 37536880)
17. p70 production in primary human monocytes. J Immunol 2006;176(12):7438-7446.
18. Levy O, Suter EE, Miller RL, and Wessels MR: Unique efficacy of Toll-like receptor 8 agonists in activating human neonatal antigen-presenting cells. Blood. 2006;108(4):1284-1290.
19. Brenchley JM, Price DA, Schacker TW, et al.: Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006;12(12):1365-1371.
20. Pasare C and Medzhitov R: Control of B-cell responses by Toll-like receptors. Nature 2005;438(7066):364-368.
21. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25(4):402-408.
22. Komai-Koma M, Jones L, Ogg GS, Xu D, and Liew FY: TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci USA 2004;101(9):3029-3034.
23. Sutmuller RP, den Brok MH, Kramer M, et al.: Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006;116(2):485-494.
24. Wesch D, Beetz S, Oberg HH, Marget M, Krengel K, and Kabelitz D: Direct costimulatory effect of TLR3 ligand poly(I:C) on human gamma delta T lymphocytes. J Immunol. 2006;176(3):1348-1354.
25. Crellin NK, Garcia RV, Hadisfar O, Allan SE, Steiner TS, and Levings MK: Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J Immunol 2005;175(12):8051-8059.
26. Marsland BJ, Nembrini C, Grun K, et al.: TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-theta signaling and promote autoimmune myocarditis. J Immunol 2007;178(6):3466-3473.
27. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, and Demengeot J: Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J Exp Med 2003;197(4):403-411.
28. Zarember KA and Godowski PJ: Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002;168(2):554-561.
29. Hornung V, Rothenfusser S, Britsch S, et al.: Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168(9):4531-4537.
30. Lester RT, Yao XD, Ball TB, et al.: Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection. AIDS 2008;22(6):685-694.
31. Langford SE, Ananworanich J, and Cooper DA: Predictors of disease progression in HIV infection: A review. AIDS Res Ther 2007;4:11.
32. Silvestri G, Sodora DL, Koup RA, et al.: Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 2003;18(3):441-452.
33. Wu L, Paxton WA, Kassam N, et al.: CCR5 levels and expression pattern correlate with infectability by macrophagetropic HIV-1, in vitro. J Exp Med 1997;185(9):1681-1691.
34. Kang SM, Tran AC, Grilli M, and Lenardo MJ: NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 1992;256(5062):1452-1456.
35. Shattock RJ, Rizzardi GP, Hayes P, and Griffin GE: Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway. J Infect Dis 1996;174(1): 54-62.
36. Swingler S, Mann A, Jacque J, et al.: HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages. Nat Med 1999;5(9):997-1103
37. Cicala C, Arthos J, Selig SM, et al.: HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc Natl Acad Sci USA 2002; 99(14):9380-9385.
38. Eggena MP, Barugahare B, Jones N, et al.: Depletion of regulatory T cells in HIV infection is associated with immune activation. J Immunol 2005;174(7):4407-4414.
39. Heggelund L, Muller F, Lien E, et al.: Increased expression of Toll-like receptor 2 on monocytes in HIV infection: Possible roles in inflammation and viral replication. Clin Infect Dis 2004;39(2):264-269.
40. Sanghavi SK and Reinhart TA: Increased expression of TLR3 in lymph nodes during simian immunodeficiency virus infection: Implications for inflammation and immunodeficiency. J Immunol 2005;175(8):5314-5323.
41. Richard KL, Filali M, Prefontaine P, and Rivest S: Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. J Neurosci 2008;28(22):5784-5793.
42. Thibault S, Tardif MR, Barat C, and Tremblay MJ: TLR2 signaling renders quiescent naive and memory CD4+ T cells more susceptible to productive infection with X4 and R5 HIV-type 1. J Immunol 2007;179(7):4357-4366.
43. Funderburg N, Luciano AA, Jiang W, Rodriguez B, Sieg SF, and Lederman MM: Toll-like receptor ligands induce human T cell activation and death, a model for HIV pathogenesis. PLoS One 2008;3(4):e1915.
44. Meier A, Alter G, Frahm N, et al.: MyD88-dependent immune activation mediated by human immunodeficiency virus type 1-encoded Toll-like receptor ligands. J Virol 2007; 81(15):8180-8191.
45. Caron G, Duluc D, Fremaux I, et al.: Direct stimulation of human T cells via TLR5 and TLR7/8: Flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells. J Immunol 2005;175(3):1551-1557.
46. Takeda K, Kaisho T, and Akira S: Toll-like receptors. Annu Rev Immunol 2003;21:335-376.